FDA Import Refusal 799-7203979-3/21/1 — Merck & Co. Inc
The FDA refused shipment 799-7203979-3/21/1 from Merck & Co. Inc (United States) on Aug 9, 2018. The refused product falls under Drugs and Biologics — MOMETASONE FUROATE (ANTI-INFECTIVE, TOPICAL). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 9, 2018
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 62FCQ53 MOMETASONE FUROATE (ANTI-INFECTIVE, TOPICAL)
- Charges
- 75